SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-04 |
| Reported value | $1,648,747,919 |
| Positions | 5 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| Arcus Biosciences Inc. | RCUS | COM | $968,825,351 | 31,424,760 |
| Lakefront Biotherapeutics | LKFT | SPON ADR | $500,157,715 | 16,707,477 |
| Assembly Biosciences Inc. | ASMB | COM NEW | $136,770,406 | 4,977,089 |
| Kyverna Therapeutics Inc. | KYTX | COM | $36,763,720 | 4,126,119 |
| Xilio Therapeutics Inc. | XLO | COM | $6,230,727 | 650,389 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.